Concepts (207)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Space Flight | 8 | 2020 | 23 | 2.120 |
Why?
|
| Cartilage, Articular | 6 | 2019 | 72 | 1.660 |
Why?
|
| Whole-Body Irradiation | 4 | 2015 | 58 | 1.410 |
Why?
|
| Knee Joint | 3 | 2019 | 128 | 1.390 |
Why?
|
| Weightlessness | 4 | 2020 | 9 | 1.260 |
Why?
|
| Hindlimb Suspension | 4 | 2019 | 11 | 1.260 |
Why?
|
| Gait | 2 | 2019 | 120 | 0.780 |
Why?
|
| Animals | 27 | 2020 | 8199 | 0.730 |
Why?
|
| Mice, Inbred C57BL | 13 | 2020 | 792 | 0.600 |
Why?
|
| Bone and Bones | 5 | 2014 | 91 | 0.560 |
Why?
|
| Hip Joint | 1 | 2019 | 68 | 0.560 |
Why?
|
| Mice | 14 | 2020 | 2571 | 0.540 |
Why?
|
| Dose-Response Relationship, Radiation | 5 | 2019 | 83 | 0.510 |
Why?
|
| Weight-Bearing | 2 | 2016 | 42 | 0.500 |
Why?
|
| Anus Neoplasms | 1 | 2016 | 13 | 0.500 |
Why?
|
| Femur Neck | 1 | 2016 | 18 | 0.500 |
Why?
|
| Arthritis | 1 | 2016 | 30 | 0.480 |
Why?
|
| Pelvis | 1 | 2016 | 67 | 0.480 |
Why?
|
| Spasm | 1 | 2016 | 6 | 0.470 |
Why?
|
| Sarcoma, Experimental | 1 | 2016 | 7 | 0.470 |
Why?
|
| Radiation, Ionizing | 2 | 2015 | 21 | 0.470 |
Why?
|
| Ribs | 1 | 2016 | 44 | 0.460 |
Why?
|
| Phantoms, Imaging | 1 | 2015 | 70 | 0.450 |
Why?
|
| Radiometry | 1 | 2015 | 52 | 0.450 |
Why?
|
| Joints | 1 | 2014 | 12 | 0.430 |
Why?
|
| Angiotensin I | 1 | 2016 | 237 | 0.410 |
Why?
|
| Muscle, Skeletal | 2 | 2016 | 520 | 0.390 |
Why?
|
| Peptide Fragments | 1 | 2016 | 415 | 0.380 |
Why?
|
| Radiosurgery | 1 | 2016 | 355 | 0.380 |
Why?
|
| Lung Neoplasms | 1 | 2016 | 423 | 0.360 |
Why?
|
| Disease Models, Animal | 5 | 2020 | 1083 | 0.360 |
Why?
|
| Osteogenesis | 3 | 2019 | 79 | 0.340 |
Why?
|
| Bone Density | 4 | 2018 | 169 | 0.340 |
Why?
|
| Male | 14 | 2020 | 19443 | 0.320 |
Why?
|
| Etidronic Acid | 1 | 2009 | 3 | 0.310 |
Why?
|
| Bone Density Conservation Agents | 1 | 2009 | 23 | 0.300 |
Why?
|
| Osteoporosis | 1 | 2009 | 51 | 0.290 |
Why?
|
| Mitochondria | 2 | 2020 | 211 | 0.280 |
Why?
|
| Osteoclasts | 1 | 2008 | 25 | 0.280 |
Why?
|
| Tibia | 4 | 2016 | 56 | 0.270 |
Why?
|
| X-Ray Microtomography | 3 | 2019 | 45 | 0.270 |
Why?
|
| Alligators and Crocodiles | 2 | 2005 | 3 | 0.260 |
Why?
|
| Locomotion | 2 | 2005 | 34 | 0.260 |
Why?
|
| Rats | 3 | 2016 | 1895 | 0.250 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2018 | 907 | 0.250 |
Why?
|
| Glycosaminoglycans | 3 | 2016 | 23 | 0.240 |
Why?
|
| Cell Proliferation | 1 | 2008 | 603 | 0.240 |
Why?
|
| Postural Balance | 1 | 2016 | 142 | 0.210 |
Why?
|
| Pesticides | 1 | 2016 | 135 | 0.210 |
Why?
|
| Time Factors | 2 | 2019 | 2205 | 0.210 |
Why?
|
| Occupational Exposure | 1 | 2016 | 159 | 0.210 |
Why?
|
| Tail | 1 | 2004 | 5 | 0.210 |
Why?
|
| Transients and Migrants | 1 | 2016 | 197 | 0.200 |
Why?
|
| Femur | 3 | 2016 | 75 | 0.200 |
Why?
|
| Emigrants and Immigrants | 1 | 2016 | 198 | 0.200 |
Why?
|
| Osteoarthritis | 2 | 2014 | 73 | 0.190 |
Why?
|
| Swine | 4 | 2019 | 228 | 0.190 |
Why?
|
| Chondrocytes | 2 | 2013 | 70 | 0.190 |
Why?
|
| Oxidative Stress | 2 | 2020 | 255 | 0.180 |
Why?
|
| Punctures | 2 | 2019 | 32 | 0.170 |
Why?
|
| Hindlimb | 2 | 2016 | 53 | 0.170 |
Why?
|
| Hispanic Americans | 1 | 2016 | 772 | 0.170 |
Why?
|
| Protons | 2 | 2012 | 22 | 0.160 |
Why?
|
| Stress, Physiological | 1 | 2020 | 56 | 0.160 |
Why?
|
| Blood-Brain Barrier | 1 | 2020 | 52 | 0.160 |
Why?
|
| Proteome | 1 | 2020 | 41 | 0.160 |
Why?
|
| Genomics | 1 | 2020 | 89 | 0.160 |
Why?
|
| Spacecraft | 1 | 2019 | 3 | 0.150 |
Why?
|
| Female | 8 | 2019 | 19947 | 0.150 |
Why?
|
| Transplantation, Heterologous | 1 | 2019 | 109 | 0.150 |
Why?
|
| Organ Size | 2 | 2018 | 221 | 0.150 |
Why?
|
| Adaptation, Ocular | 1 | 2019 | 4 | 0.150 |
Why?
|
| Extremities | 1 | 2019 | 54 | 0.150 |
Why?
|
| Blood-Retinal Barrier | 1 | 2019 | 5 | 0.150 |
Why?
|
| Osteoblasts | 2 | 2019 | 43 | 0.150 |
Why?
|
| Tissue Transplantation | 1 | 2019 | 17 | 0.150 |
Why?
|
| Tissue Culture Techniques | 1 | 2019 | 42 | 0.150 |
Why?
|
| Menisci, Tibial | 1 | 2019 | 20 | 0.150 |
Why?
|
| Retina | 1 | 2019 | 86 | 0.140 |
Why?
|
| Amnion | 1 | 2019 | 36 | 0.140 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2019 | 65 | 0.140 |
Why?
|
| Thoracic Vertebrae | 1 | 2018 | 39 | 0.140 |
Why?
|
| Ascorbic Acid | 1 | 2018 | 21 | 0.130 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2019 | 165 | 0.130 |
Why?
|
| Musculoskeletal Diseases | 1 | 2018 | 33 | 0.130 |
Why?
|
| Lumbar Vertebrae | 1 | 2018 | 97 | 0.130 |
Why?
|
| Gene Expression Regulation | 1 | 2019 | 478 | 0.130 |
Why?
|
| Humans | 9 | 2020 | 32284 | 0.130 |
Why?
|
| Middle Aged | 4 | 2017 | 11853 | 0.130 |
Why?
|
| Antioxidants | 1 | 2018 | 122 | 0.130 |
Why?
|
| Immunohistochemistry | 2 | 2016 | 545 | 0.130 |
Why?
|
| Body Weight | 2 | 2016 | 323 | 0.120 |
Why?
|
| Macaca mulatta | 1 | 2018 | 340 | 0.120 |
Why?
|
| Probability | 1 | 2016 | 155 | 0.120 |
Why?
|
| Tissue Scaffolds | 1 | 2019 | 431 | 0.120 |
Why?
|
| Bone Neoplasms | 1 | 2017 | 117 | 0.120 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2019 | 1224 | 0.120 |
Why?
|
| Rib Fractures | 1 | 2016 | 21 | 0.120 |
Why?
|
| Fractures, Bone | 1 | 2017 | 142 | 0.120 |
Why?
|
| Muscle Neoplasms | 1 | 2016 | 8 | 0.120 |
Why?
|
| Radiotherapy Dosage | 1 | 2016 | 107 | 0.120 |
Why?
|
| International Agencies | 1 | 2015 | 10 | 0.120 |
Why?
|
| Radiobiology | 1 | 2015 | 5 | 0.120 |
Why?
|
| Mice, Inbred Strains | 1 | 2016 | 55 | 0.120 |
Why?
|
| Congresses as Topic | 1 | 2015 | 42 | 0.120 |
Why?
|
| Biopsy, Needle | 1 | 2016 | 95 | 0.110 |
Why?
|
| Adult | 3 | 2016 | 9259 | 0.110 |
Why?
|
| Weightlessness Simulation | 1 | 2015 | 1 | 0.110 |
Why?
|
| Oncostatin M | 1 | 2015 | 2 | 0.110 |
Why?
|
| Particle Accelerators | 1 | 2015 | 7 | 0.110 |
Why?
|
| Reference Values | 1 | 2016 | 238 | 0.110 |
Why?
|
| Fibrosis | 1 | 2016 | 126 | 0.110 |
Why?
|
| Radiation Injuries | 1 | 2016 | 85 | 0.110 |
Why?
|
| Research | 1 | 2015 | 81 | 0.110 |
Why?
|
| Information Dissemination | 1 | 2015 | 52 | 0.110 |
Why?
|
| Collagen | 1 | 2016 | 229 | 0.110 |
Why?
|
| Random Allocation | 1 | 2016 | 247 | 0.110 |
Why?
|
| Case-Control Studies | 3 | 2019 | 854 | 0.110 |
Why?
|
| Environmental Exposure | 1 | 2015 | 60 | 0.110 |
Why?
|
| Analysis of Variance | 1 | 2016 | 471 | 0.110 |
Why?
|
| Logistic Models | 1 | 2016 | 743 | 0.110 |
Why?
|
| Nanotechnology | 1 | 2014 | 18 | 0.110 |
Why?
|
| Prostatic Neoplasms | 1 | 2019 | 489 | 0.110 |
Why?
|
| Sensitivity and Specificity | 1 | 2016 | 556 | 0.110 |
Why?
|
| Lower Extremity | 1 | 2015 | 100 | 0.110 |
Why?
|
| Rats, Inbred F344 | 1 | 2014 | 151 | 0.100 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2016 | 897 | 0.100 |
Why?
|
| Aged | 4 | 2019 | 10265 | 0.100 |
Why?
|
| Brain | 1 | 2020 | 965 | 0.100 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2013 | 5 | 0.100 |
Why?
|
| Matrix Metalloproteinase 13 | 1 | 2013 | 10 | 0.100 |
Why?
|
| Fibronectins | 1 | 2013 | 39 | 0.100 |
Why?
|
| X-Rays | 2 | 2013 | 7 | 0.100 |
Why?
|
| Proteoglycans | 1 | 2012 | 34 | 0.090 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2012 | 85 | 0.090 |
Why?
|
| Signal Transduction | 2 | 2013 | 727 | 0.090 |
Why?
|
| Cell Survival | 1 | 2012 | 288 | 0.090 |
Why?
|
| Aged, 80 and over | 2 | 2017 | 3902 | 0.090 |
Why?
|
| DNA | 1 | 2012 | 223 | 0.090 |
Why?
|
| Cells, Cultured | 2 | 2013 | 839 | 0.080 |
Why?
|
| Cosmic Radiation | 1 | 2009 | 10 | 0.080 |
Why?
|
| Humerus | 1 | 2009 | 31 | 0.070 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2009 | 108 | 0.070 |
Why?
|
| Rabbits | 2 | 2019 | 219 | 0.070 |
Why?
|
| Apoptosis | 2 | 2020 | 375 | 0.070 |
Why?
|
| Cell Line | 2 | 2019 | 454 | 0.060 |
Why?
|
| Cell Differentiation | 2 | 2019 | 461 | 0.060 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2004 | 20 | 0.050 |
Why?
|
| Spinal Cord Injuries | 1 | 2004 | 44 | 0.050 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2004 | 51 | 0.050 |
Why?
|
| Postoperative Complications | 2 | 2019 | 823 | 0.050 |
Why?
|
| Models, Biological | 1 | 2005 | 408 | 0.050 |
Why?
|
| Cytokines | 1 | 2004 | 237 | 0.050 |
Why?
|
| North Carolina | 1 | 2016 | 1300 | 0.050 |
Why?
|
| Radiography | 2 | 2018 | 363 | 0.040 |
Why?
|
| Organ Specificity | 1 | 2020 | 80 | 0.040 |
Why?
|
| Circadian Rhythm | 1 | 2020 | 46 | 0.040 |
Why?
|
| Biological Transport | 1 | 2020 | 75 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 1 | 2020 | 196 | 0.040 |
Why?
|
| Muscles | 1 | 2020 | 69 | 0.040 |
Why?
|
| Smell | 1 | 2020 | 45 | 0.040 |
Why?
|
| Immunity, Innate | 1 | 2020 | 82 | 0.040 |
Why?
|
| Lipid Metabolism | 1 | 2020 | 108 | 0.040 |
Why?
|
| United States | 2 | 2019 | 4072 | 0.040 |
Why?
|
| Bone Substitutes | 1 | 2019 | 9 | 0.040 |
Why?
|
| Ecological Systems, Closed | 1 | 2019 | 1 | 0.040 |
Why?
|
| Retinal Rod Photoreceptor Cells | 1 | 2019 | 6 | 0.040 |
Why?
|
| Retinal Cone Photoreceptor Cells | 1 | 2019 | 6 | 0.040 |
Why?
|
| Crystallins | 1 | 2019 | 1 | 0.040 |
Why?
|
| Aquaporin 4 | 1 | 2019 | 1 | 0.040 |
Why?
|
| Vision, Ocular | 1 | 2019 | 33 | 0.040 |
Why?
|
| Elastic Modulus | 1 | 2019 | 29 | 0.040 |
Why?
|
| Pressure | 1 | 2019 | 69 | 0.040 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2019 | 44 | 0.040 |
Why?
|
| Retinal Pigment Epithelium | 1 | 2019 | 25 | 0.040 |
Why?
|
| Intraocular Pressure | 1 | 2019 | 41 | 0.040 |
Why?
|
| Eye Proteins | 1 | 2019 | 36 | 0.040 |
Why?
|
| Cluster Analysis | 1 | 2019 | 120 | 0.040 |
Why?
|
| Visual Acuity | 1 | 2019 | 76 | 0.040 |
Why?
|
| Neovascularization, Physiologic | 1 | 2019 | 114 | 0.040 |
Why?
|
| Extracellular Matrix | 1 | 2020 | 256 | 0.040 |
Why?
|
| Proteomics | 1 | 2019 | 97 | 0.030 |
Why?
|
| Needles | 1 | 2018 | 29 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2019 | 193 | 0.030 |
Why?
|
| Complex Regional Pain Syndromes | 1 | 2018 | 24 | 0.030 |
Why?
|
| Medicare | 1 | 2019 | 219 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2017 | 456 | 0.030 |
Why?
|
| Stress, Mechanical | 2 | 2008 | 96 | 0.030 |
Why?
|
| Length of Stay | 1 | 2017 | 321 | 0.030 |
Why?
|
| Dietary Supplements | 1 | 2018 | 188 | 0.030 |
Why?
|
| Osteoprotegerin | 1 | 2015 | 2 | 0.030 |
Why?
|
| RANK Ligand | 1 | 2015 | 6 | 0.030 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2015 | 14 | 0.030 |
Why?
|
| Glycoproteins | 1 | 2015 | 34 | 0.030 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2015 | 100 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2015 | 224 | 0.030 |
Why?
|
| Tissue Engineering | 1 | 2019 | 695 | 0.030 |
Why?
|
| Hydroxyproline | 1 | 2013 | 10 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2013 | 54 | 0.020 |
Why?
|
| Risk Factors | 1 | 2019 | 3934 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2019 | 3628 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2017 | 3416 | 0.020 |
Why?
|
| Radiation Dosage | 1 | 2009 | 91 | 0.020 |
Why?
|
| Synchrotrons | 1 | 2008 | 3 | 0.020 |
Why?
|
| Sunlight | 1 | 2008 | 17 | 0.020 |
Why?
|
| Ultraviolet Rays | 1 | 2008 | 48 | 0.020 |
Why?
|
| Electromyography | 1 | 2005 | 67 | 0.010 |
Why?
|